Finerenone — Dosing in CKD & Dialysis

Finerenone (Nonsteroidal Mineralocorticoid Receptor Antagonist): renal dosing adjustments, dialyzability (Unlikely to be efficiently removed by hemodialysis (plasma protein binding about 90%; Kerendia label section 10)), and renal-relevant safety risk for CKD and dialysis patients. Educational refer

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.